Contact Us

Edit Template

Abstract Guidelines

PRESENTATION OPTIONS

  • Choose between Oral or Poster presentations.
  1. Virtual- ORAL PRESENTATION (20 minutes Talk)
  2. Virtual- POSTER PRESENTATION (10 Minutes Talk)
  • Both original and previously published abstracts are welcome.
  • All submissions undergo peer review by our committee.
  • Early submissions qualify for discounted registration rates.

SUBMISSION DETAILS

  • Submit your abstract through our website ( Submit Abstact Here ).
  • Please use the abstract template and follow the same structure. (Download Here)
  • Avoid duplicate submissions.
  • Each participant can submit up to 2 abstracts.

SUBMISSION RULES

  • All abstracts must be submitted and presented in clear English with accurate grammar and spelling of a quality suitable for publication.
  • The committee operates a single / double-blind peer review process for all the abstracts submitted
  • Authors will be notified of their abstract status within a week.
  • Accepted authors will receive an official acceptance letter via email.
  • Please contact the Program Manager ( [email protected] ) if you have not received confirmation that your abstract has been received.

SUBMISSION GUIDELINES

  • Presenting authors must be registered participants. Only abstracts of authors who have paid their registration fees will be scheduled in the program.
  • Presenting author can be replaced by one of the co-authors only.
  • Accepted abstracts will be published in official conference book only.
  • Abstracts that have been presented at another meeting may be submitted
  • Changes will be made to submitted and accepted abstracts and it should be requested in writing an email.

BEFORE YOU BEGIN

Before you begin, kindly prepare the following information:

Presenting Author contact information:

  • Email address
  • Full postal address
  • Phone number
  • Author and co-authors’ details
  • Authors’ names must be in upper and lower case (J.C.C. Smith)
  • Affiliation information: department, institution / hospital, city state (if relevant), country
  • Abstract title – Limited to 25-35 words
  • Abstract text – Limited to 250-300 words
  • Use only standard abbreviations. Place special or unusual abbreviations in parentheses after the full word the first time it appears.
  • Use generic names of drugs. Express numbers as numerals
  • You will receive an abstract reference number via email after you have submitted your abstract.
  • After submitting your abstract, you can still make changes up until the deadline.
  • Abstract topic– abstracts must be allocated to a specific topic for the scientific program. You will need to select the category most suited to your abstract.

DECLARATION

During abstract submission you will be asked to confirm that you agree to the following:

  • I confirm that I previewed this abstract and that all information is correct. I accept that the content of this abstract cannot be modified or corrected after final submission and I am aware that it will be published as submitted.
  • Submission of the abstract constitutes the consent of all authors to publication (e.g. Conference website, programs, other promotions, etc.)
  • The Abstract Submitter grants each of the Organizers the license and right to use, reproduce, publish, translate, distribute, and display the Content or any part thereof, in any manner and on any platform or media whatsoever, in each Organizer’s absolute discretion, on a royalty-free, perpetual, irrevocable nonexclusive basis.
  • I herewith confirm that the contact details saved in this system are those of the presenting author, who will be notified about the status of the abstract. The presenting author is responsible for informing the other authors about the status of the abstract. The submitting author may request to be copied on the abstract correspondence.
  • I understand that the presenting author must be a registered participant.
  • The Organizers reserve the right to remove from publication and/or presentation an abstract that does not comply with the above.
  • I understand that I must select a specific Topic and Sub-Topic for my abstract allocation. Although the Committee will work hard to honour this selection, this cannot be guaranteed.  The Committee reserves the right to change the Topic and Sub-Topic under which the abstract was originally submitted.

REVIEW PROCESS

  • All abstracts will be reviewed by the Scientific Programme? Committee. The committee operates a single / double-blind peer review process for all the abstracts submitted, where both the reviewer and the author remain anonymous.

  • When abstracts are submitted, they are immediately reviewed in-house to see if they conform to accepted academic norms, and to screen out incomplete, out-of-scope, poorly written, or time-wasting submissions.

  • Presenting authors will be notified via e-mail regarding the status of their abstracts within a week after submission. Accepted authors will receive an email notifying them of the results, as well as an official letter of acceptance as a PDF

By adhering to these guidelines, you can streamline the submission process and increase your chances of acceptance. We look forward to receiving your abstracts!

Contact Us

If you have any questions about these Guidelines, You can contact our Program Manager:

About Us

With over 500+ researchers from 30+ countries, G-CARE 2026 highlights underrepresented voices and groundbreaking discoveries —  A Summit Without Borders

Driving equitable cancer research through global collaboration and innovation and bridging borders to accelerate cancer care solutions for all.

© 2020-2026 Organized by VYYOMA INTENRATIONAL